Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019
Emerging Infectious Diseases · 2024
DOI: 10.3201/eid3005.231694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2024. Verfasst von Kentaro Tohma und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Norovirus, Caliciviridae Infections, Gastroenteritis, Antigens, Viral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Norovirus is a major cause of acute gastroenteritis; GII.4 is the predominant strain in humans. Recently, 2 new GII.4 variants, Hong Kong 2019 and San Francisco 2017, were reported. Characterization using GII.4 monoclonal antibodies and serum demonstrated different antigenic profiles for the new variants compared with historical variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Tohma, K., Landivar, M., Ford-Siltz, L. A., Pilewski, K. A., Kendra, J. A., Niendorf, S., & Parra, G. I. (2024). Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019. Emerging Infectious Diseases. https://doi.org/10.3201/eid3005.231694
Vancouver
Tohma K, Landivar M, Ford-Siltz LA, Pilewski KA, Kendra JA, Niendorf S, et al. Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019. Emerging Infectious Diseases. 2024. doi:10.3201/eid3005.231694
BibTeX
@article{Tohma2024,
author = {Tohma, Kentaro and Landivar, Michael and Ford-Siltz, Lauren A and Pilewski, Kelsey A and Kendra, Joseph A and Niendorf, Sandra and Parra, Gabriel I},
title = {Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019},
journal = {Emerging Infectious Diseases},
year = {2024},
doi = {10.3201/eid3005.231694}
}
EUVIMED